Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms and Services), By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Other Technologies) - Global Opportunity Analysis and Industry Forecast, 2014-2022
- ALL1177708
- 162 Pages
- April 2017
- Medical Devices
Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. The global next generation sequencing market accounted for $3,567 million in 2015, and is anticipated to reach $12,801 million by 2022, registering a CAGR of 19.9% from 2016 to 2022. NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.
Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drives the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and rise in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.
The next generation sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, the market is segmented into consumables, platforms, and services. The consumables product segment is further classified on the basis of sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment and quality control. The platform NGS product segment is bifurcated into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. In the NGS product segment, consumables occupied dominant share in 2015, and the segment is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of NGS.
Based on application, this market is bifurcated into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2015, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D throughout the world along with surge in awareness about NGS applications in precision medicine. Based on technology, the next generation sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Sequencing by synthesis technology held the greatest share in 2015 and this trend is estimated to continue throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing and structural variation detection, sequence assembly & others respectively..
Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.
Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.
KEY PLAYERS PROFILED
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- Beijing Genomics Institute
- Qiagen N.V.
- 454 Life Sciences Corporation (Roche Holding AG)
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Genomatix GmbH
- PierianDx.
KEY MARKET BENEFITS
- The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents quantitative analysis of the market for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on product type assists in understanding the trends in the industry.
- Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry
Next generation sequencing Market Key Segments:
By Product
- Consumables
- Sample Preparation Consumables
- DNA Fragmentation, End Repair, A-Tailing and Size Selection
- Library Preparation & Target Enrichment
- Quality Control
- Other Consumables
- Sample Preparation Consumables
- Platforms
- HiSeq
- MiSeq
- Ion Torrent
- SOLiD
- Pacbio Rs II and Sequel System
- Other Sequencing Platforms
- Services
- Sequencing Services
- RNA Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Targeted Sequencing
- Chip Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Data Management Services
- NGS Data Analysis Services
- NGS Data Analysis Software & Workbenches
- NGS Storage, Management and Cloud Computing Solutions
- Sequencing Services
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Other Technologies
By End User
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Other players in the value chain include (profiles not included in the report)
- Eurofins Scientific
- Gatc Biotech AG
- Macrogen, Inc.
- Oxford Nanopore Technologies, Ltd.
- Bio-Rad Laboratories, Inc.
- DNASTAR, Inc.
- Biomatters Ltd.
- Partek Inc.
- New England Biolabs, Inc.
- Myriad Genetics, Inc.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENTS ANALYSIS
3.3.1. Patent analysis by year
3.3.2. Patent analysis by region
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Technological advancements in NGS
3.5.1.2. Surge in applications of NGS
3.5.1.3. Increase in partnerships and collaborations
3.5.1.4. Increase in genome mapping programs
3.5.2. Restraints
3.5.2.1. Standardization concerns over NGS based diagnostics
3.5.2.2. Lack of skilled professionals
3.5.2.3. Ethical and legal limitations
3.5.3. Opportunities
3.5.3.1. Lucrative opportunities in emerging markets
3.5.3.2. Cloud computing: potential data management service
CHAPTER 4 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. CONSUMABLES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Sample preparation consumables
4.2.4.1. DNA fragmentation, end repair, A-tailing, and size selection
4.2.4.2. Library preparation & target enrichment
4.2.4.3. Quality Control
4.2.1. Other consumables
4.3. PLATFORMS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Hiseq series
4.3.5. Miseq series
4.3.6. ION Torrent
4.3.7. SOLiD
4.3.8. Pacbio Rs II and Sequel system
4.3.9. Other Sequencing Platforms
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
4.4.4. Sequencing services
4.4.4.1. Market size & forecast
4.4.4.2. RNA sequencing
4.4.4.3. Whole exome sequencing
4.4.4.4. Whole genome sequencing
4.4.4.5. Targeted sequencing
4.4.4.6. Chip sequencing
4.4.4.7. De Novo sequencing
4.4.4.8. Methyl sequencing
4.4.1. Data management services
4.4.1.1. NGS data analysis services
4.4.1.2. NGS data analysis software & workbenches
4.4.1.3. NGS storage, management, and cloud computing solutions
CHAPTER 5 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. BIOMARKERS AND CANCER
5.2.1. Market size & forecast
5.3. DIAGNOSTICS
5.3.1. Market size & forecast
5.4. REPRODUCTIVE HEALTH
5.4.1. Market size & forecast
5.5. PERSONALIZED MEDICINE
5.5.1. Market size & forecast
5.6. AGRICULTURE AND ANIMAL RESEARCH
5.6.1. Market size & forecast
5.7. OTHER APPLICATIONS
5.7.1. Market size & forecast
CHAPTER 6 GLOBAL NEXT GENERATION SEIQNCING MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. SEQUENCING BY SYNTHESIS (SBS)
6.2.1.1. Market size & forecast
6.3. ION SEMICONDUCTOR SEQUENCING (IOS)
6.4. SEQUENCING BY LIGATION (SBL)
6.4.1. Market size & forecast
6.5. PYROSEQUENCING
6.5.1. Market size & forecast
6.6. SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
6.6.1. Market size & forecast
6.7. OTHER TECHNOLOGIES
6.7.1. Market size & forecast
CHAPTER 7 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
7.2.1. Market size & forecast
7.3. PHARMACEUTICAL COMPANIES
7.3.1. Market size & forecast
7.4. BIOTECHNOLOGY COMPANIES
7.4.1. Market size & forecast
7.5. HOSPITALS & CLINICS
7.5.1. Market size & forecast
CHAPTER 8 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size & forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.2.4. Mexico
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. AGILENT TECHNOLOGIES, INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. BEIJING GENOMICS INSTITUTE
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Key strategic moves and developments
9.3. GENOMATIX GMBH
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.4. ILLUMINA, INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. PERKINELMER, INC.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. PIERIANDX
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. QIAGEN N.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. ROCHE HOLDING AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. THERMO FISHER SCIENTIFIC, INC.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2. GLOBAL NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. DNA FRAGMENTATION, END REPAIR, A-TAILING & SIZE SELECTION: KEY PRODUCTS
TABLE 4. LIBRARY PREPARATION & TARGET ENRICHMENT: KEY PRODUCTS
TABLE 5. GLOBAL NEXT GENERATION SEQUENCING PLATFORM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6. GLOBAL NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 7. SEQUENCING SERVICES GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8. NGS DATA ANALYSIS SOFTWARE & WORKBENCHES: KEY PRODUCTS
TABLE 9. NGS STORAGE MANAGEMENT AND CLOUD COMPUTING: KEY PRODUCTS
TABLE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 11. BIOMARKERS AND CANCER NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 12. DIAGNOSTICS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 13. REPRODUCTIVE HEALTH NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 14. PERSONALISED MEDICINE NEXT GENERATION SEQUENCING, BY REGION, 2014-2022 ($MILLION)
TABLE 15. AGRICULTURE AND ANIMAL RESEARCH NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 16. OTHER APPLICATIONS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 18. SEQUENCING BY SYNTHESIS TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 19. ION SEMICONDUCTOR SEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 20. SEQUENCING BY LIGATION TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 21. PYROSEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET TECHNOLOGY, BY REGION, 2014-2022 ($MILLION)
TABLE 22. SINGLE-MOLECULE-REAL-TIME-SEQUENCING TECHNOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 23. OTHER TECHNOLOGIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 24. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USERS, 2014-2022 ($MILLION)
TABLE 25. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 26. PHARMACEUTICAL COMPANIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 27. BIOTECHNOLOGY COMPANIES NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 28. HOSPITALS & CLINICS NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 29. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 30. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 31. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 32. NORTH AMERICA CONSUMABLES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 33. NORTH AMERICA PLATFORMS NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 34. NORTH AMERICA SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35. NORTH AMERICA SEQUENCING SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 36. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION , 2014-2022 ($MILLION)
TABLE 37. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY , 2014-2022 ($MILLION)
TABLE 38. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY END USER , 2014-2022 ($MILLION)
TABLE 39. EUROPE NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 40. EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 41. EUROPE NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 42. EUROPE NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 43. EUROPE NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 44. EUROPE NEXT GENERATION SEQUENCING SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 45. EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 46. EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 47. EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 48. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 49. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 50. ASIA-PACIFIC NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 51. ASIA-PACIFIC NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 52. ASIA-PACIFIC NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 53. ASIA-PACIFIC NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 57. LAMEA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 58. LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 59. LAMEA NEXT GENERATION SEQUENCING CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 60. LAMEA NEXT GENERATION SEQUENCING PLATFORMS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 61. LAMEA NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 62. LAMEA NEXT GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 63. LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 64. LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 65. LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 66. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 67. THERMO FISHER SCIENTIFIC, INC.,: COMPANY SNAPSHOT
TABLE 68. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,: COMPANY SNAPSHOT
TABLE 69. BEIJING GENOMICS INSTITUTE: COMPANY SNAPSHOT
TABLE 70. QIAGEN N.V.,: COMPANY SNAPSHOT
TABLE 71. LIFE SCIENCES CORPORATION (ROCHE HOLDING AG) : COMPANY SNAPSHOT
TABLE 72. AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT
TABLE 73. PERKINELMER, INC. : COMPANY SNAPSHOT
TABLE 74. GENOMATIX GMBH: COMPANY SNAPSHOT
TABLE 75. PIERIANDX: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
FIGURE 2. PATENT ANALYSIS BY YEAR
FIGURE 3. PATENT ANALYSIS BY REGION
FIGURE 4. BARGAINING POWER OF BUYERS
FIGURE 5. BARGAINING POWER OF SUPPLIERS
FIGURE 6. THREAT OF NEW ENTRANTS
FIGURE 7. THREAT OF SUBSTITUTION
FIGURE 8. COMPETITIVE RIVALRY
FIGURE 9. DRIVERS AND RESTRAINTS: GLOBAL NEXT GENERATION SEQUENCING MARKET
FIGURE 10. NGS MARKET: PRODUCT & SERVICES SEGMENATION
FIGURE 11. U.S. NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 12. CANADA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 13. MEXICO NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 14. MEXICO NEXT GENERATION SEQUENCING MARKET, 2014-2022
FIGURE 15. GERMANY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 16. FRANCE NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 17. UK NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 18. ITALY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 19. SPAIN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 20. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 21. JAPAN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 22. CHINA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 23. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 24. INDIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 25. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 26. TAIWAN NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 28. BRAZIL NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 29. TURKEY NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 30. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
FIGURE 31. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, 2014-2022 ($MILLION)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
